Tryptophan and Kynurenic Acid May Produce an Amplified Effect in Central Fatigue Induced by Chronic Sleep Disorder

International Journal of Tryptophan Research

Volumn 7, Issue , 2014, Pages 9-14

  Yamashita, Masatoshi ^a   Yamamoto, Takanobu ^a  

^a TEZUKAYAMA UNIVERSITY   (Japan)

Author keywords

5 Hydroxytryptamine; Central fatigue; Kynurenic acid; Sleep disorder; Tryptophan; endorphin

Indexed keywords

EID: 84988353460     PISSN: None     EISSN: 11786469     Source Type: Journal    
DOI: 10.4137/IJTR.S14084     Document Type: Article

References (39)

1. Farmer A, Fowler T, Scourfield J, Thapar A. Prevalence of chronic disabling fatigue in children and adolescents. Br J Psychiatry. 2004;184:477-81.
2. Miike T. Childhood type chronic fatigue syndrome and school phobia. J Clin Exp Med. 2009;228:710-6.
3. Tomoda A, Miike T, Uezono K, Kawasaki T. A school refusal case with biological rhythm disturbance and melatonin therapy. Brain Dev. 1994;16:71-6.
4. Tomoda A, Miike T, Yonamine K, Adachi K, Shiraishi S. Disturbed circadian core body temperature rhythm and sleep disturbance in school refusal children and adolescents. Biol Psychiatry. 1997;41:810-3.
5. Tomoda A, Jhodoi T, Miike T. Chronic fatigue syndrome and abnormal biological rhythms in school children. J Chronic Fatigue Syndr. 2001;8:29-37.
6. Tomoda A, Miike T, Yamada E, et al. Chronic fatigue syndrome in childhood. Brain Dev. 2000;22:60-4.
7. Yamamoto T, Castell LM, Botella J, et al. Changes in the albumin binding of tryptophan during postoperative recovery: a possible link with central fatigue? Brain Res Bull. 1997;43:43-6.
8. Acworth I, Nicholass J, Morgan B, Newsholme EA. Effect of sustained exercise on concentrations of plasma aromatic and branched-chain amino acids and brain amines. Biochem Biophys Res Commun. 1986;137:149-53.
9. Cermak N, Yamamoto T, Meeusen R, Burke LM, Stear SJ, Castell LM. A-Z of nutritional supplements: dietary supplements, sports nutrition foods and ergogenic aids for health and performance: part 38. Br J Sports Med. 2012;46:1027-8.
10. Blomstrand E, Perrett D, Parry-Billings M, Newsholme EA. Effect of sustained exercise on plasma amino acid concentrations and on 5-hydroxytryptamine metabolism in six different brain regions in the rat. Acta Physiol Scand. 1989;136:473-81.
11. Kinn AM, Grønli J, Fiske E, et al. A double exposure to social defeat induces sub-chronic effects on sleep and open field behaviour in rats. Physiol Behav. 2008;95:553-61.
12. Yamamoto T, Azechi H, Board M. Essential role of excessive tryptophan and its neurometabolites in fatigue. Can J Neurol Sci. 2012;39:40-7.
13. Yamamoto T, Newsholme EA. Tryptophan and central fatigue. Fatigue Sci. 2005;204:35-41.
14. Herz A, Millan MJ. Opioids and opioid receptors mediating antinociception at various levels of the neuraxis. Physiol Bohemoslov. 1990;39:395-401.
15. Suganuma T, Suzuki T, Oshimi M, Hanano M. Change of beta-endorphin concentration in rat brain after administration of indomethacin or carrageenin. Biol Pharm Bull. 1998;21:756-60.
16. Sforzo GA. Opioids and exercise. An update. Sports Med. 1989;7:109-24.
17. Mimasa F, Hayashi T, Shibata M, Yoshitake Y, Nishijima Y, Moritani T. Movement of electroencephalogram and plasma ß-endorphin in the aerobic exercise. Jpn J Phys Fitness Sports Med. 1996;45:519-26.
18. Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med. 1996;2:1382-5.
19. Esposito P, Gheorghe D, Kandere K, et al. Acute stress increases permeability of the blood-brain barrier through activation of brain mast cells. Brain Res. 2001;888:117-27.
20. Yamashita M, Yamamoto T. Establishment of a rat model of central fatigue induced by chronic sleep disorder and excessive brain tryptophan. Jpn J Cogn Neurosci. 2013;15:67-74.
21. Glowinski J, Iversen LL. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem. 1966;13:655-69.
22. Swartz KJ, Matson WR, MacGarvey U, Ryan EA, Beal MF. Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. Anal Biochem. 1990;185:363-76.
23. Pocivavsek A, Wu HQ, Elmer GI, Bruno JP, Schwarcz R. Pre-and postnatal exposure to kynurenine causes cognitive deficits in adulthood. Eur J Neurosci. 2012;35:1605-12.
24. File SE. The use of social interaction as a methods for detecting anxiolytic activity of chlordiazepoxide-like drugs. J Neurosci Methods. 1980;2:219-38.
25. File SE, Seth P. A review of 25 years of the social interaction test. Eur J Pharmacol. 2003;463:35-53.
26. Starr KR, Price GW, Watson JM, et al. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology. 2007;32:2163-72.
27. Yamamoto T, Newsholme EA. Central fatigue, exercise and behavior. J Health Phys Edu Rec. 2002;52:198-202.
28. Yamamoto T, Newsholme EA. The effect of tryptophan deficiency in the brain on rat fatigue levels: a rat model of fatigue reduction. Adv Exp Med Biol. 2003;527:527-30.
29. Schwarcz R, Pellicciari R. Manipulation of brain kynurenines: glial target, neuronal effect, and clinical opportunities. J Pharmacol Exp Ther. 2002;303:1-10.
30. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci. 2001;21:7463-73.
31. Carpenedo R, Pittaluga A, Cozzi A, et al. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci. 2001;13:2141-7.
32. Dombret C, Nguyen T, Schakman O, et al. Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus. Hum Mol Genet. 2012;21:4703-17.
33. Lopatina O, Inzhutova A, Salmina AB, Higashida H. The roles of oxytocin and CD38 in social or parental behaviors. Front Neurosci. 2012;6:182.
34. van den Burg EH, Neumann ID. Bridging the gap between GPCR activation and behavior: oxytocin and prolactin signalling in the hypothalamus. J Mol Neurosci. 2011;43:200-8.
35. Gallager DW, Aghajanian GK. Inhibition of firing of raphe neurons by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602. Neuropharmachology. 1976;15:149-56.
36. Wu HQ, Pereira EF, Bruno JP, Pellicciari R, Albuquerque EX, Schwarcz R. The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex. J Mol Neurosci. 2010;40:204-10.
37. Curzon P, Anderson DJ, Nikkel AL, et al. Antisense knockdown of the rat alpha7 nicotinic acetylcholine receptor produces spatial memory impairment. Neurosci Lett. 2006;410:15-9.
38. Iaccarino HF, Suckow RF, Xie S, Bucci DJ. The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: implications for schizophrenia. Schizophr Res. 2013;150:392-7.
39. Coppola A, Wenner BR, Ilkayeva O, et al. Branched-chain amino acids alter neurobehavioral function in rats. Am J Physiol Endocrinol Metab. 2013;304:E405-13.